Alliance Global Partners Begins Coverage on Pluri (NASDAQ:PLUR)

Alliance Global Partners assumed coverage on shares of Pluri (NASDAQ:PLUR) in a report released on Monday morning,Benzinga reports. The brokerage issued a buy rating and a $12.00 price objective on the stock.

Pluri Trading Up 0.2%

PLUR opened at $4.47 on Monday. Pluri has a 12 month low of $3.33 and a 12 month high of $7.13. The stock has a market capitalization of $35.01 million, a price-to-earnings ratio of -0.80 and a beta of 0.77. The company has a debt-to-equity ratio of 4.44, a current ratio of 5.04 and a quick ratio of 5.04. The business has a fifty day moving average price of $4.60 and a 200 day moving average price of $4.60.

Pluri (NASDAQ:PLUR) last announced its quarterly earnings results on Tuesday, May 13th. The company reported ($0.94) earnings per share (EPS) for the quarter. Pluri had a negative return on equity of 2,778.13% and a negative net margin of 3,551.49%. The business had revenue of $0.43 million for the quarter.

Institutional Trading of Pluri

An institutional investor recently raised its position in Pluri stock. Renaissance Technologies LLC raised its stake in shares of Pluri Inc. (NASDAQ:PLUR) by 38.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 34,025 shares of the company’s stock after acquiring an additional 9,400 shares during the period. Renaissance Technologies LLC owned approximately 0.61% of Pluri worth $145,000 as of its most recent SEC filing. Institutional investors own 16.59% of the company’s stock.

Pluri Company Profile

Pluri Inc, a biotechnology company, engages in the development of placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions. It operates in the field of regenerative medicine, food-tech, and biologics and focuses on establishing partnerships that leverage its 3D cell-based technology to additional industries that require mass cell production.